Please assess the completion status of the following clinical trial:

Trial Title: Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men 18 yrs. or older~* An elevated PSA (\>2.5 ng/ml) and normal digital rectal exam~* Have elected to proceed with a diagnostic 12-core prostate biopsy~Exclusion Criteria:~* Previous prostate biopsy~* History of prostate cancer~* Urinary tract infections or prostatitis within one year of study entry~* antibiotic use within one month prior to PSA level~* pyuria or bacteruria on urinalysis~* allergy to fluoroquinolones

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Observation (Type: NO_INTERVENTION): Observation only for 2 weeks
- Antibiotic (Type: ACTIVE_COMPARATOR): Ciprofloxacin 500 mg twice daily for 2 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).